Residual cardiovascular risk after ACS in oncologic patients: the prognostic role of persistently elevated NT proBNP.

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Coronary disease and cardiovascular toxicity in patients with cancer Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology